A new look for a new era
Our new identity will enable us to expand our services, accomplish global growth objectives, and foster and develop client relationships.
Introducing our consultancy service
Our specialist IP consultancy division is aimed at helping clients use intellectual property solutions to address common business challenges.
Creating value from innovation
We have one clearly defined purpose that provides us with the context and meaning for the work we do every day. We are committed to using our expertise to solve the IP challenges you face so your innovations can reach their full commercial potential.
One Team, one Potter Clarkson
Wildbore & Gibbons is now officially part of the Potter Clarkson brand – one team, all working together to deliver exceptional service for clients.
OUR SERVICES
Potter Clarkson creates value from your innovation. We bring vision and clarity of thought to guide you through the complexities of intellectual property for business. As consultants and experts in IP law, we help you understand, create, protect and defend the commercial value of your innovations anywhere in the world.
-
PATENTS
-
TRADE MARKS
-
DESIGNS
-
LITIGATION AND LICENSING
-
CONSULTANCY
HOW CAN WE HELP?
EVENTS
-
- Date
- Event name
- Location
-
View Materials Research Exchange 2020
- Materials Research Exchange 2020
- London
-
View Graphene Industry Showcase 2019
- Graphene Industry Showcase 2019
- Manchester
-
View The Graphene Hackathon
- The Graphene Hackathon
- Manchester
THE DIFFERENCE WE MAKE
Helping our clients to achieve their commercial objectives is a powerfully motivating force. When we see breakthrough innovations making a difference in the world, it is hugely satisfying and the main reason we love our work.
Successful trade mark oppositions for leading Italian bank
As part of a long-standing relationship with an Italian IP firm, we have advised one of Italy’s largest banking groups, on UK trade mark matters.
Global pharmaceutical company successfully defends patent for use of antidepressant medicine
We were instructed by two global pharmaceutical companies, H. Lundbeck A/S and Takeda Pharmaceuticals, to defend an opposition filed against their patent to an antidepressant medication vortioxetine (marketed as Brintellix).
Full-service IP approach means fast-track robotics SME can focus on growth
With a need to balance scientific invention with commercial objectives, the company needed IP advisers who could both gain the confidence of its scientists and engineers and help it meet its commercial objectives.
